Notably, Foxo3 upregulation has not been specifically observed in colon cancer cells treated with butyrate, although Foxo3 expression does modulate a number of pro-apoptotic genes associated with butyrate’s antineoplastic effects [48]. This evidence concerns the gene FOXO3 and colonic neoplasm.